Looking at the chart it would appear that anyone who bought since late 2018 and is selling now is taking a bath. The question is "why??" I'm inching toward the top 20 but the top 20 keep getting bigger. With clinical trials within a year appearing to be a certainty and those trials having all the pointers to success I believe my patience will be amply rewarded. This latest addition to to Partys team is a specialist in clinical trials and to my way of thinking is one huge insurance policy that everything will be managed to perfection.
Ann: Patrys strengthens executive team on path to clinic, page-10
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.46M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $10.87K | 1.362M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 6159941 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 280000 | 1 |
View Market Depth
| Last trade - 15.52pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.8¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.7¢ | 0.8¢ | 0.7¢ | 150544 | ||
| Last updated 14.09pm 10/05/2024 ? | |||||
| PAB (ASX) Chart |